Biohaven Ltd.$16.02 %
Analyst Rating: Hold
Stock Details
CEO
Vladimir Coric
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
256
Address
215 Church Street, New Haven, CT, 06510
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Biohaven Ltd. $16.02
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results